Thalidomide and beyond: some recommendations regarding public policies toward the ethical drug industry

Int J Health Serv. 1974 Winter;4(1):147-55. doi: 10.2190/DCU8-7F68-E48J-4ER5.
No abstract available

MeSH terms

  • Commerce
  • Drug Industry*
  • Drug and Narcotic Control*
  • Ethics, Pharmacy*
  • Fees, Pharmaceutical
  • Humans
  • Legislation, Pharmacy
  • Licensure
  • Pharmaceutical Preparations / standards
  • Politics
  • Research Support as Topic
  • Thalidomide / adverse effects
  • Therapeutic Equivalency
  • United States
  • United States Food and Drug Administration

Substances

  • Pharmaceutical Preparations
  • Thalidomide